logo
Select company
Select metric
-3307.99%Operating Cash Flow Margin
VS
Market
3
Sector
11
Industry
19
History
24
$ 9.42Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -33.94M-3307.99%$ 1.03M
3/31/2025$ -30.86M-90.32%$ 34.17M
12/31/2024$ -23.67M-60.84%$ 38.91M
9/30/2024$ -39.96M-83.35%$ 47.94M
6/30/2024$ -62.86M-116.2%$ 54.1M
3/31/2024$ -58.31M-225.09%$ 25.91M
12/31/2023$ -51.16M-196.74%$ 26M
9/30/2023$ -39.72M-115.03%$ 34.53M
6/30/2023$ -26.16M-53.72%$ 48.69M
3/31/2023$ -28.53M-34.49%$ 82.72M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at 258.89%.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average OCF % has been -195.38%.
  • The median OCF % for CARTESIAN THERAPEUTICS INC during this period was -54.78%
  • CARTESIAN THERAPEUTICS INC reached its highest OCF % over the past 5 years at 258.89%.
  • The lowest OCF % recorded by CARTESIAN THERAPEUTICS INC in the same timeframe -3307.99%

CARTESIAN THERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
HUMA : HUMACYTE INC -12774.82%NWBO : NORTHWEST BIOTHERAPEUTICS INC -4069.47%MREO : MEREO BIOPHARMA GROUP PLC -6583.8%INBX : INHIBRX BIOSCIENCES INC -9989.21%CRDF : CARDIFF ONCOLOGY INC -7663.92%BTAI : BIOXCEL THERAPEUTICS INC -6424.54%CATX : PERSPECTIVE THERAPEUTICS INC -5244.94%ADVM : ADVERUM BIOTECHNOLOGIES INC -13091.1%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -1031.07%LSTA : LISATA THERAPEUTICS INC -1533.08%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for CARTESIAN THERAPEUTICS INC is calculated as follows: CF - Operations [ $ 29.25M ] / Revenues [ $ 11.3M ]
(=) OCF % [ 258.89% ]

RNAC - Operating Cash Flow Margin, Last 5 years

-3307.99%

Minimum

Jun 30, 2025

258.89%

Maximum

Sep 30, 2020

-195.38%

Average

-54.78%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.33% with a standard deviation of 21.12%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.33%
median12.67%
std21.12%